Earnings Feed
Start Free
BIO-TECHNE Corp·4

Nov 2, 3:17 PM ET

KEEGAN JOSEPH D 4

4 · BIO-TECHNE Corp · Filed Nov 2, 2020

Insider Transaction Report

Form 4
Period: 2020-10-29
BIO-TECHNE CorpTECH
KEEGAN JOSEPH D
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-10-29+1,507→ 1,507 total
    Exercise: $255.69Exp: 2030-10-29→ Common Stock (1,507 underlying)
  • Award

    Common Stock

    2020-10-29+391→ 2,139 total
Holdings

  • Stock Option (Right to Buy)

    Exercise: $179.84From: 2019-10-24Exp: 2028-10-25→ Common Stock (1,898 underlying)
    1,898

  • Stock Option (Right to Buy)

    Exercise: $201.64From: 2020-10-24Exp: 2029-10-24→ Common Stock (2,011 underlying)
    2,011

  • Stock Option (Right to Buy)

    Exercise: $125.05From: 2018-10-25Exp: 2027-10-26→ Common Stock (3,125 underlying)
    3,125
Footnotes (1)
  • [F1]The option vests on the earlier of the one year anniversary of the grant date (10/29/2020) or the date of Bio-Techne's 2021 annual meeting of shareholders.

Documents

2 files